| Due Diligence for Asset Managers |
|---|
|
You have viewed 7 of the 10 daily limit Subscribe for $29/month to gain full access |
|
⚲
|
| Keyboard |
| Prelude Therapeutics Inc | |
|---|---|
| Ticker | PRLD |
| CIK # | 0001678660 |
| CUSIP | 74065P101 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 200 Powder Mill Road, Wilmington, DE 19803 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Prelude Therapeutics Inc | 2020-08-28 | 50.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001678660] | 10-K | |
| [0001678660] | 10-Q | |
| [0001678660] | 3 | |
| [0001678660] | 4 | |
| [0001678660] | 8-K | |
| [0001678660] | D | |
| [0001678660] | SC 13D | |
| [0001678660] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Combs Andrew
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 230,000 | $0.00 | |
|
Scherle Peggy
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 230,000 | $0.00 | |
|
Lim Bryant David
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 275,000 | $0.00 | |
|
Vaddi Krishna
Employee Stock Option (right to buy) · derivative
|
2026-02-04 | Grant | 837,000 | $0.00 | |
|
Sandor Victor
Director Stock Option (Right to Buy) · derivative
|
2025-11-05 | Grant | 121,285 | $0.00 | |
|
Dorton Katina
Director Stock Option (Right to Buy) · derivative
|
2025-10-17 | Grant | 76,000 | $0.00 | |
|
Huang Jane
Restricted Stock Unit · derivative
|
2025-10-04 | Option exercise | 9,375 | $0.00 | |
|
Huang Jane
Common Stock
|
2025-10-04 | Tax withheld | 3,355 | $1.47 | 4,932 |
|
Huang Jane
Common Stock
|
2025-10-04 | Option exercise | 9,375 | ||
|
Huang Jane
Restricted Stock Unit · derivative
|
2025-07-04 | Option exercise | 9,375 | $0.00 | |
|
Huang Jane
Common Stock
|
2025-07-04 | Option exercise | 9,375 | ||
|
Huang Jane
Common Stock
|
2025-07-04 | Tax withheld | 3,355 | $0.79 | 2,650 |
|
Bonita David P
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Babler Martin
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 76,000 | $0.00 | |
|
Baker Brothers Life Sciences LP +5
Non- Qualified Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 76,000 | $0.00 | |
|
Sandor Victor
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Dier Mardi
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Friedman Paul A
Director Stock Option (Right to Buy) · derivative
|
2025-06-12 | Grant | 38,000 | $0.00 | |
|
Huang Jane
Restricted Stock Unit · derivative
|
2025-04-04 | Option exercise | 9,375 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 55 | 30,734,775 |
| 2025-12-31 | 48 | 28,518,467 |
| 2025-09-30 | 47 | 27,166,015 |
| 2025-06-30 | 51 | 27,190,915 |
| 2025-03-31 | 60 | 30,559,064 |
| 2024-12-31 | 63 | 32,176,760 |
| 2024-09-30 | 71 | 35,761,458 |
| 2024-06-30 | 62 | 33,923,877 |
| 2024-03-31 | 59 | 34,811,015 |
| 2023-12-31 | 57 | 35,035,180 |
| 2023-09-30 | 61 | 36,615,887 |
| 2023-06-30 | 56 | 38,549,517 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 230 | 230 | Prev | Page 1 | Next |